Skip to main content

Table 1 Baseline characteristics

From: Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: statistical analysis plan for a randomised controlled trial (UPGRADE trial)

 

UDCA (n=)

Placebo (n=)

Age—years, mean (SD)

  

Sex—F, n (% n/N)

  

Ethnicity

 Dutch

  

 Surinamese

  

 Dutch Caribbean

  

 Moroccan

  

 Turkish

  

 Others

  

Baseline weight—kg

  

Baseline BMI—kg/m2

  

Hypertension—yes, n (% n/N)

  

Dyslipidaemia—yes, n (% n/N)

  

Type 2 diabetes—yes, n (% n/N)

  

Pain syndrome—yes, n (% n/N)

  

History of abdominal surgery—yes, n (% n/N)

  

Medication prior to surgery—yes, n (% n/N)

  

 Statins

  

 Birth control pills

  

 Oestrogen

  

Preoperative cholecystolithiasis—yes, n (% n/N)

  

Type of surgery—RYGB, n (% n/N)

  

Baseline health utility scoren, mean (SD)